Skip to main content
Figure 1 | Transplantation Research

Figure 1

From: An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation

Figure 1

Treatment and follow-up schedule in the SAILOR-study. ATG, antithymocyte globulin; AUC, area under the plasma concentration time curve; IL2-R, interleukin-2 receptor; mGFR, measured glomerular filtration rate; MMF, mycophenolate mofetil; oGTT, oral glucose tolerance test; Tx, transplant.

Back to article page

Transplantation Research

ISSN: 2047-1440

Contact us